Breaking News Instant updates and real-time market news.

NEE

NextEra Energy

$252.14 /

-0.13 (-0.05%)

10:23
01/17/20
01/17
10:23
01/17/20
10:23

NextEra Energy downgraded to Neutral from Outperform at Credit Suisse

Credit Suisse analyst Michael Weinstein downgraded NextEra Energy to Neutral from Outperform.

  • 24

    Jan

NEE NextEra Energy
$252.14 /

-0.13 (-0.05%)

01/17/20 KeyBanc
NextEra Energy downgraded to Sector Weight on valuation at KeyBanc
01/17/20 KeyBanc
NextEra Energy downgraded to Sector Weight from Overweight at KeyBanc
01/15/20 Goldman Sachs
NextEra Energy downgraded to Neutral from Buy at Goldman Sachs
01/15/20 Goldman Sachs
NextEra Energy downgraded to Neutral from Buy at Goldman Sachs

TODAY'S FREE FLY STORIES

General news
FX Update: The dollar, yen and Swiss franc have outperformed » 03:40
02/24/20
02/24
03:40
02/24/20
03:40

FX Update: The dollar,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Valmont Industries downgraded to Hold from Buy at Stifel » 21:48
02/23/20
02/23
21:48
02/23/20
21:48
VMI

Valmont

$133.94 /

-0.66 (-0.49%)

Stifel analyst Nathan…

Stifel analyst Nathan Jones downgraded Valmont Industries to Hold from Buy with a price target of $137, down from $168. The analyst no longer believes his previous positive thesis on the shares is valid. Execution missteps and "significant, unexpected" losses in the company's Access Systems business make a Buy rating no longer justified, Jones tells investors in a research note.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Keurig Dr Pepper upgraded to Equal Weight from Underweight at Morgan Stanley » 20:12
02/23/20
02/23
20:12
02/23/20
20:12
KDP

Keurig Dr Pepper

$29.51 /

+0.21 (+0.72%)

Morgan Stanley analyst…

Morgan Stanley analyst Dara Mohsenian upgraded Keurig Dr Pepper to Equal Weight from Underweight with a $29 price target.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
OneSmart upgraded to Overweight from Equal Weight at Morgan Stanley » 20:11
02/23/20
02/23
20:11
02/23/20
20:11
ONE

OneSmart

$4.95 /

-0.37 (-6.95%)

Morgan Stanley analyst…

Morgan Stanley analyst Sheng Zhong upgraded OneSmart to Overweight from Equal Weight with a $7 price target.

Hot Stocks
Fly Intel: Top five weekend stock stories » 19:37
02/23/20
02/23
19:37
02/23/20
19:37
CAT

Caterpillar

$137.25 /

+0.325 (+0.24%)

, VIACA

ViacomCBS

$32.82 /

-0.895 (-2.65%)

, VIAC

ViacomCBS

$28.26 /

-1.03 (-3.52%)

, I

Intelsat

$4.50 /

-0.03 (-0.66%)

, BA

Boeing

$330.39 /

-5.885 (-1.75%)

, INTU

Intuit

$297.77 /

-3.47 (-1.15%)

, KR

Kroger

$30.31 /

+0.53 (+1.78%)

, SPCE

Virgin Galactic

$33.70 /

-3.49 (-9.38%)

Catch up on the…

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Intuit (INTU) is nearing a deal to buy Credit Karma for about $7B in cash and stock, The Wall Street Journal's Cara Lombardo and Dana Cimilluca wrote, citing people familiar with the matter. The maker of TurboTax could announce a deal to buy privately held Credit Karma by Monday, assuming talks don't fall apart, the people said. Credit Karma was valued at roughly $4B in a private share sale about two years ago, the authors noted. 2. Boeing (BA) has confirmed it found debris that could pose potential safety risks in the fuel tanks of several 737 Max aircraft that are in storage and waiting to be delivered to airlines, according to Reuters. Boeing officials called the findings "absolutely unacceptable," the report noted. 3. Intelsat's stock (I) could again become a casualty in a 5G showdown among hedge-fund managers, satellite operators, and the federal government, Alexandra Scaggs wrote in this week's edition of Barron's. The company's satellites transmit television signals over the so-called C-band, which is considered to be prime for fifth-generation, or 5G, service, with regulators wanting to clear out 60% of it for use by wireless companies, the author noted. A consortium of satellite operators called the C-Band Alliance volunteered to sell the spectrum privately in a plan that could have brought Intelsat as much as $24B, but the problem is that a private sale would require the Federal Communications Commission to give satellite operators the ability to sell rights they do not currently have, in the regulator's view, the author added. 4. ViacomCBS (VIAC) subsidiary Paramount's "Sonic the Hedgehog" stayed at number one, grossing another $26.3M in its second weekend in theaters and bringing its total to $106.6M. Overseas, the movie earned $38.3M in 56 markets. "Sonic the Hedgehog" sports an A CinemaScore and a 63% Rotten Tomatoes rating. 5. Caterpillar (CAT) and Kroger (KR) saw positive mentions in this week's edition of Barron's, while Virgin Galactic (SPCE) was mentioned cautiously.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Monster Beverage price target raised to $78 from $71 at Stifel » 19:08
02/23/20
02/23
19:08
02/23/20
19:08
MNST

Monster Beverage

$69.69 /

-0.71 (-1.01%)

Stifel analyst Mark…

Stifel analyst Mark Astrachan raised the firm's price target on Monster Beverage to $78 from $71 and keeps a Buy rating on the shares. The stock closed Friday down 66c to 69.74. The analyst thinks Monster's 2020 U.S. sales could exceed 7.0%, more than 100 basis points above consensus expectations of 5.5% to 6.0%, driven by accelerating Reign sales, pending innovation, and improving legacy Monster sales. Reign sales have accelerated since Fall 2019, now accounting for 3.6% market share of the U.S. energy drink market, Astrachan tells investors in a research note. Further, lower aluminum costs provide more favorable U.S. gross margin and could bring modest upside to earnings estimates, adds the analyst.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
TC Energy upgraded to Neutral from Sell at Goldman Sachs » 18:25
02/23/20
02/23
18:25
02/23/20
18:25
TRP

TC Energy

$57.39 /

+0.05 (+0.09%)

Goldman Sachs analyst…

Goldman Sachs analyst Michael Lapides upgraded TC Energy to Neutral from Sell given lower balance sheet concerns due to asset sales, a high proportion of EBITDA from its low risk, but solid growth gas pipeline business in Western Canada, and to reflect more accurately historical trading trends. The analyst bases his upgrade on lower equity financing risk given the sale of non-core assets and strategic partnerships on large-scale growth projects, and a higher applied valuation multiple, to more accurately reflect a sustainable premium relative to peers, especially given TC Energy's lower risk business model.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Enbridge downgraded to Sell from Neutral at Goldman Sachs » 18:23
02/23/20
02/23
18:23
02/23/20
18:23
ENB

Enbridge

$41.87 /

+0.115 (+0.28%)

Goldman Sachs analyst…

Goldman Sachs analyst Michael Lapides downgraded Enbridge to Sell from Neutral. The analyst believes after sizable outperformance and a major share price rally recently, risk/reward appears more unfavorable now - especially given our EBITDA estimates appear below consensus.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Box Office Battle: 'Sonic the Hedgehog' wins weekend again with $26.5M » 17:14
02/23/20
02/23
17:14
02/23/20
17:14
T

AT&T

$38.54 /

-0.075 (-0.19%)

, CMCSA

Comcast

$45.81 /

-0.21 (-0.46%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

, SNE

Sony

$65.92 /

-0.78 (-1.17%)

, LGF.A

Lionsgate

$10.01 /

-0.25 (-2.44%)

, LGF.B

Lionsgate

$9.40 /

-0.24 (-2.49%)

, DIS

Disney

$138.93 /

-1.42 (-1.01%)

, VIACA

ViacomCBS

$32.82 /

-0.895 (-2.65%)

, VIAC

ViacomCBS

$28.26 /

-1.03 (-3.52%)

ViacomCBS (VIAC)…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Envestnet return profile just improved following correction, says Jefferies » 16:47
02/23/20
02/23
16:47
02/23/20
16:47
ENV

Envestnet

$78.97 /

-7.43 (-8.60%)

Jefferies analyst…

Jefferies analyst Surinder Thind lowered his price target for Envestnet to $97 from $96, while keeping a Buy rating on the shares. For investors who were on the fence, the analyst sees the stock as being even more attractively valued following its roughly 10% correction post Q4 results, which optically look worse than underlying fundamentals. Thind believes a divestiture of Yodlee or a sale of the company is a 70% probability event that can bring instant value. If not, fast forward 1 year, and he sees the stock above current levels, propelled by the prospect of returning to 15%-20% earnings growth.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Boeing to offer more support for Max suppliers, WSJ reports » 16:19
02/23/20
02/23
16:19
02/23/20
16:19
BA

Boeing

$330.39 /

-5.885 (-1.75%)

, EADSY

Airbus

$0.00 /

+ (+0.00%)

Boeing (BA) is planning…

Boeing (BA) is planning more support for suppliers for its 737 Max jetliner to prepare them for restarting production-and to dissuade some from seeking more business from Airbus (EADSY), The Wall Street Journal's Doug Cameron writes. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Amazon in Holocaust row about 'Hunters' series, Reuters reports » 16:16
02/23/20
02/23
16:16
02/23/20
16:16
AMZN

Amazon.com

$2,094.29 /

-58.64 (-2.72%)

The Auschwitz Memorial…

The Auschwitz Memorial criticized Amazon for fictitious depictions of the Holocaust in its Prime series "Hunters" and for selling books of Nazi propaganda, according to Reuters. "Hunters" features a team of Nazi hunters in 1970s New York who discover that hundreds of escaped Nazis are living in the U.S., the report notes. However, the series has faced accusations of bad taste, particularly for depicting fictional atrocities in Nazi death camps. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
French Minister says no global digital tax deal would mean chaos,Reuters reports » 16:11
02/23/20
02/23
16:11
02/23/20
16:11
GOOG

Alphabet

$1,484.27 /

-33.78 (-2.23%)

, GOOGL

Alphabet Class A

$1,482.84 /

-33.7 (-2.22%)

, FB

Facebook

$210.11 /

-4.43 (-2.06%)

, AMZN

Amazon.com

$2,094.29 /

-58.64 (-2.72%)

France's Finance…

France's Finance minister said that failure to reach a global deal on where and how much to tax digital giants such as Google (GOOGL), Amazon (AMZN) or Facebook (FB) would result in many digital tax regimes emerging all over the world, Reuters' Jan Strupczewski writes. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kadmon announces expanded results of interim analysis of KD025 trial in cGVHD » 16:05
02/23/20
02/23
16:05
02/23/20
16:05
KDMN

Kadmon

$5.08 /

+0.03 (+0.59%)

Kadmon announced expanded…

Kadmon announced expanded results from the previously reported interim analysis of ROCKstar, its ongoing pivotal trial of KD025 in chronic graft-versus-host disease. As announced in November 2019, KD025 met the primary endpoint of Overall Response Rate at the study's planned interim analysis, two months after completion of enrollment. KD025 showed statistically significant and clinically meaningful ORRs of 64% with KD025 200 mg once daily and 67% with KD025 200 mg twice daily. In the expanded KD025-213 dataset presented, ORRs were consistent with the previously reported interim analysis across key subgroups, including in patients with four or more organs affected by cGVHD, patients who had prior treatment with ibrutinib and patients who had prior treatment with ruxolitinib. Three patients achieved a Complete Response. Responses were observed in all affected organ systems, including in organs with fibrotic disease. KD025 has been well tolerated: adverse events were consistent overall with those expected to be observed in cGVHD patients receiving corticosteroids, and no apparent increased risk of infection was observed. Additional secondary endpoints, including duration of response, corticosteroid dose reductions, Failure-Free Survival, Overall Survival and Lee Symptom Scale reductions continue to mature and will be available later in 2020. At the TCT Meetings, Kadmon also presented long-term follow-up data from KD025-208, its ongoing Phase 2 study of KD025 in cGVHD. These data were recently presented at the 61st American Society of Hematology Annual Meeting and Exposition in December 2019.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Spherix announces special dividend distribution » 16:02
02/23/20
02/23
16:02
02/23/20
16:02
HOTH

Hoth Therapeutics

$4.41 /

+ (+0.00%)

, SPEX

Spherix

$1.03 /

+0.015 (+1.49%)

Spherix (SPEX) announced…

Spherix (SPEX) announced that on February 21, 2020, a special committee of the Board of Directors of Spherix approved a distribution to Spherix stockholders of 70,000 shares of Hoth Therapeutics (HOTH) held by Spherix. Each Spherix stockholder will be entitled to receive one share of Hoth common stock for every seventy shares of Spherix common stock held as of 5 p.m. Eastern Time on March 4, 2020, the record date. Spherix will not distribute fractional shares of Hoth common stock, and any fractional shares will be rounded down to the nearest whole share.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Intuit near deal to buy Credit Karma for $7B in cash and stock, WSJ reports » 09:58
02/23/20
02/23
09:58
02/23/20
09:58
INTU

Intuit

$297.77 /

-3.47 (-1.15%)

Intuit is nearing a deal…

Intuit is nearing a deal to buy Credit Karma for about $7B in cash and stock, Wall Street Journal's Cara Lombardo and Dana Cimilluca report, citing people familiar with the matter. The maker of TurboTax could announce a deal to buy privately held Credit Karma by Monday, assuming talks don't fall apart, the people said. Credit Karma was valued at roughly $4B in a private share sale about two years ago, the authors note. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Volkswagen to face first U.S. jury trial, Bloomberg reports » 07:29
02/23/20
02/23
07:29
02/23/20
07:29
VWAGY

Volkswagen

$0.00 /

+ (+0.00%)

Volkswagen faces a new…

Volkswagen faces a new reckoning over its diesel-emissions scandal - its first U.S. jury trial, Bloomberg's Malathi Nayak writes. The automaker says it has paid plenty to right wrongs, but hundreds of car owners who declined to join a $10B settlement contend it has not repented enough, the author notes. A trial set to begin Monday in San Francisco federal court will subject Volkswagen to fresh scrutiny and more negative publicity almost five years after it admitted that about 11M of its diesel vehicles worldwide were outfitted with so-called defeat devices that gave false readings during emissions tests, the report adds. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Twitter suspends group of pro-Bloomberg accounts over manipulation, Reuters says » 07:26
02/23/20
02/23
07:26
02/23/20
07:26
TWTR

Twitter

$38.31 /

-0.73 (-1.87%)

Twitter said it had…

Twitter said it had started suspending and restricting dozens of accounts posting content promoting U.S. Democratic presidential candidate Michael Bloomberg, Reuters' Elizabeth Culliford writes. "We took enforcement action on about 70 accounts, which includes a combination of permanent suspensions and account challenges to verify ownership," a Twitter spokeswoman said in a statement to Reuters. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Boeing finds debris inside 737 Max fuel tanks, Reuters reports » 07:24
02/23/20
02/23
07:24
02/23/20
07:24
BA

Boeing

$330.39 /

-5.885 (-1.75%)

Boeing has confirmed it…

Boeing has confirmed it found debris that could pose potential safety risks in the fuel tanks of several 737 Max aircraft that are in storage and waiting to be delivered to airlines, according to Reuters. Boeing officials called the findings "absolutely unacceptable," the report notes. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
The ASTCT and CIBMTR to hold a joint meeting » 04:55
02/23/20
02/23
04:55
02/23/20
04:55
ABBV

AbbVie

$94.96 /

+0.7 (+0.74%)

, ADPT

Adaptive Biotechnologies

$34.19 /

+0.37 (+1.09%)

, AMGN

Amgen

$222.80 /

+0.62 (+0.28%)

, ATNM

Actinium Pharmaceuticals

$0.26 /

+0.0088 (+3.50%)

, ATRA

Atara Biotherapeutics

$13.18 /

-0.34 (-2.51%)

, AZN

AstraZeneca

$50.17 /

+1.2 (+2.45%)

, BLUE

Bluebird Bio

$80.15 /

-2.38 (-2.88%)

, CDNA

CareDx

$28.25 /

+0.13 (+0.46%)

, CDTX

Cidara Therapeutics

$3.16 /

+ (+0.00%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, EQ

Equillium

$5.48 /

+0.38 (+7.45%)

, GMDA

Gamida Cell

$4.55 /

-0.2 (-4.21%)

, GSK

GlaxoSmithKline

$43.11 /

+0.35 (+0.82%)

, HUM

Humana

$369.65 /

-1.9 (-0.51%)

, INCY

Incyte

$80.89 /

-1.88 (-2.27%)

, JAZ

Jazz Technologies

$0.00 /

+ (+0.00%)

, KDMN

Kadmon

$5.08 /

+0.03 (+0.59%)

, MGTA

Magenta Therapeutics

$14.00 /

-0.02 (-0.14%)

, MRK

Merck

$82.34 /

-0.14 (-0.17%)

, NVS

Novartis

$96.75 /

+0.44 (+0.46%)

, PFE

Pfizer

$35.71 /

-0.13 (-0.36%)

, RCKT

Rocket Pharmaceuticals

$22.73 /

-1.01 (-4.25%)

, SGEN

Seattle Genetics

$117.00 /

-1.3 (-1.10%)

, SNY

Sanofi

$50.83 /

+0.07 (+0.14%)

, TAK

Takeda Pharmaceutical

$18.78 /

+0.195 (+1.05%)

American Society for…

American Society for Transplantation & Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) hold the 2020 TCT: Transplantation & Cellular Therapy Meeting will be held in Orlando on February 19-23.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Buffett 'almost certain' stocks will beat bonds if current rates, taxes hold » 14:21
02/22/20
02/22
14:21
02/22/20
14:21
BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

, SPY

SPDR S&P 500 ETF Trust

$333.48 /

-3.49 (-1.04%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

Warren Buffet said in his…

Warren Buffet said in his annual letter to shareholders, "What we can say is that if something close to current rates should prevail over the coming decades and if corporate tax rates also remain near the low level businesses now enjoy, it is almost certain that equities will over time perform far better than long-term, fixed-rate debt instruments."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Buffett's Berkshire spent $5B buying back own shares in 2019 » 14:19
02/22/20
02/22
14:19
02/22/20
14:19
BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

Warren Buffet said in his…

Warren Buffet said in his annual letter to shareholders, "In past reports, we've discussed both the sense and nonsense of stock repurchases. Our thinking, boiled down: Berkshire will buy back its stock only if a) Charlie and I believe that it is selling for less than it is worth and b) the company, upon completing the repurchase, is left with ample cash. Calculations of intrinsic value are far from precise. Consequently, neither of us feels any urgency to buy an estimated $1 of value for a very real 95 cents. In 2019, the Berkshire price/value equation was modestly favorable at times, and we spent $5 billion in repurchasing about 1% of the company. Over time, we want Berkshire's share count to go down. If the price-to-value discount (as we estimate it) widens, we will likely become more aggressive in purchasing shares. We will not, however, prop the stock at any level."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Buffett says Berkshire '100% prepared' for his, Munger's departure » 14:17
02/22/20
02/22
14:17
02/22/20
14:17
BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

Warren Buffet said in his…

Warren Buffet said in his annual letter to shareholders, "Charlie and I long ago entered the urgent zone. That's not exactly great news for us. But Berkshire shareholders need not worry: Your company is 100% prepared for our departure. The two of us base our optimism upon five factors. First, Berkshire's assets are deployed in an extraordinary variety of wholly or partly-owned businesses that, averaged out, earn attractive returns on the capital they use. Second, Berkshire's positioning of its "controlled" businesses within a single entity endows it with some important and enduring economic advantages. Third, Berkshire's financial affairs will unfailingly be managed in a manner allowing the company to withstand external shocks of an extreme nature. Fourth, we possess skilled and devoted top managers for whom running Berkshire is far more than simply having a high-paying and/or prestigious job. Finally, Berkshire's directors - your guardians - are constantly focused on both the welfare of owners and the nurturing of a culture that is rare among giant corporations...Today, my will specifically directs its executors - as well as the trustees who will succeed them in administering my estate after the will is closed - not to sell any Berkshire shares. My will also absolves both the executors and the trustees from liability for maintaining what obviously will be an extreme concentration of assets."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Berkshire Hathaway reports Q4 net earnings $4.42B vs. $5.72B last year » 14:06
02/22/20
02/22
14:06
02/22/20
14:06
BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

At December 31, 2019,…

At December 31, 2019, Berkshire's insurance float was approximately $129B, an increase of $6B since year-end 2018.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
CommScope downgraded to Hold from Buy at Deutsche Bank » 14:02
02/22/20
02/22
14:02
02/22/20
14:02
COMM

CommScope

$12.62 /

+0.07 (+0.56%)

Deutsche Bank analyst…

Deutsche Bank analyst Vijay Bhagavath downgraded CommScope to Hold from Buy citing expected 2020 volatility following the company's Q4 results.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.